Save American Lives and Prosperity by Cutting the FDA Bureaucracy

In this American Greatness article, Thaddeus G. McCotter argues that slashing the FDA’s bloated bureaucracy for assessing drug effectiveness—while maintaining rigorous safety standards—could save countless American lives, slash costs, and restore U.S. medical innovation leadership.

• FDA drug approvals take roughly a decade, with most delays stemming from effectiveness reviews rather than safety, creating Byzantine obstacles that harm patients in desperate need.
• An Unleash Prosperity report estimates that shaving just one year off effectiveness reviews could generate up to $10 trillion in innovations, savings, and lower drug prices through increased competition.
• Reforms would counter China’s faster, cheaper clinical trials, reducing dangerous reliance on adversarial nations for medical research.
• Key proposals include greater AI use, a Cancer Warp Speed Office, expanded concurrent reviews for serious conditions, post-market effectiveness monitoring, and broader Right to Try access.
• President Trump, HHS Secretary RFK Jr., and FDA Commissioner Marty Makary have launched a pilot program to accelerate early trials and streamline approvals.
• Overregulation literally costs lives by jamming the drug pipeline with outdated 1970s-era processes that ignore modern tools like AI and private-sector advances.
• Comprehensive FDA reform represents a pro-life, pro-prosperity imperative to unleash American ingenuity and deliver timely treatments to those who need them most.

Read the full story:
https://amgreatness.com/2026/06/27/save-american-lives-and-prosperity-by-cutting-the-fda-bureaucracy/